Abstract: Provided are methods for treating GLUT1 and related brain energy deficiencies comprising administering odd-carbon fatty acid sources, e.g., C5 or C7 fatty acid sources, and related compositions.
Type:
Grant
Filed:
September 6, 2016
Date of Patent:
October 30, 2018
Assignees:
National Institute of Health and Medical Research, Baylor Research Institute
Abstract: Provided are methods for treating GLUT1 and related brain energy deficiencies comprising administering odd-carbon fatty acid sources, e.g., C5 or C7 fatty acid sources, and related compositions.
Type:
Grant
Filed:
December 13, 2013
Date of Patent:
October 18, 2016
Assignees:
NATIONAL INSTITUTE OF HEALTH AND MEDICAL RESEARCH, BAYLOR RESEARCH INSTITUTE
Abstract: Provided are methods for treating GLUT1 and related brain energy deficiencies comprising administering odd-carbon fatty acid sources, e.g., C5 or C7 fatty acid sources, and related compositions.
Type:
Application
Filed:
December 13, 2013
Publication date:
August 7, 2014
Applicants:
Baylor Research Institute at Dallas, National Institute of Health and Medical Research
Abstract: Phorbine derivatives having high potency and light absorptivity in the 650 to 780 nanometer range are useful in cancer diagnosis and therapy, especially photodynamic therapy.
Type:
Grant
Filed:
September 24, 1993
Date of Patent:
February 20, 1996
Assignees:
Fox Chase Cancer Center, The French National Institute of Health and Medical Research (Inserm), Yissum Research Development Company of the Hebrew University of Jerusalem
Inventors:
Shimon Gatt, Arie Dagan, Rene Santus, Jean-Claude Maziere, J. Donald Chapman, Edward L. Engelhardt